Back to top
more

Fidelity Advisor Biotechnology Fund: Class I: (MF: FBTIX)

(NASDAQ Mutual Funds) As of Aug 20, 2026 05:21 PM ET

$55.70 USD

-1.98 (-3.43%)

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

1-Strong Buy of 5 1        

View All Zacks Mutual Fund Rank #1's

Latest Performance as of Jul 31, 2026

Total Return %* Percentile Rank Objective
YTD 20.80 6
3 months 15.66 8
6 months 19.12 7
1 Year 62.62 7
3 Year 24.98 4
5 Year 12.88 1
10 Year 12.88 3

* Annual for three years and beyond.

Zacks Premium Research for FBTIX

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Strong Buy 1
MF Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

% Unrealized Gain 46.77
% Yield 0.94
% SEC Yield NA
Net Assets (Mil $) 7/31/2026 906.66
% Turnover 7/31/2026 55.00

Risk

3 Year 5 Year 10 Year
Beta 0.62 0.51 0.70
Alpha 11.71 5.50 2.86
R Squared 0.12 0.14 0.25
Std. Dev. 21.97 21.04 21.14
Sharpe 0.96 0.50 3.00

Sector / Country Weightings

As of 7/31/2026 % of Portfolio
Health 62.42
Other 17.51
Services 16.68
Industrial Cyclical 3.22
Finance 0.17

Portfolio Holdings

Top Equity Holdings
(As of 4/30/2026)
% of Portfolio Value (Mil$)
ABBVIE INC 14.83 282.21
ALNYLAM PHARMACEUTICALS I 5.52 105.07
GILEAD SCIENCES INC 5.42 103.22
INSMED INC 3.51 66.75
COGENT BIOSCIENCES INC 3.45 65.67
DIANTHUS THERAPEUTICS INC 3.37 64.10
SPYRE THERAPEUTICS INC 3.33 63.41
ASCENDIS PHARMA AS ADR 3.24 61.75
ARGENX SE ADR 3.17 60.35

Stock Holding % of Net Assets

As Of 4/30/2026
Total Issues 89
Avg. P/E 43.82
Avg. P/Book 5.07
Avg. EPS Growth 15.5
Avg. Market Value (Mil $) 86,424

Composition

% of Portfolio
Stocks 97.58
Foreign Stocks 9.30
Cash 3.03
Bonds 0.00
Foreign Bonds 0.00
Preferred 0.00
Convertible 1.68
Other -2.28
Foreign Hedged 0.00

Style Analysis

% of Portfolio
Large Growth 0.00
Large Value 0.76
Small Growth 13.03
Small Value 0.00
Foreign Stock 11.41
Emerging Market 0.00
Precious Metal 0.25
Intermediate Bond 12.94
Foreign Bond 0.91
High Yield Bond 0.00